Variant report
Variant | nsv828554 |
---|---|
Chromosome Location | chr19:43268818-43648725 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4926)
- CpG islands (count:2380)
- Chromatin interactive region (count:7)
- LncRNA region (count:49)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF3 | chr19:43336336-43336928 | A549 | lung: | n/a | n/a |
2 | ATF3 | chr19:43355412-43355889 | A549 | lung: | n/a | n/a |
3 | ATF3 | chr19:43336349-43336838 | A549 | lung: | n/a | n/a |
4 | ATF3 | chr19:43335349-43336094 | A549 | lung: | n/a | n/a |
5 | ATF3 | chr19:43335307-43336092 | A549 | lung: | n/a | n/a |
6 | ATF3 | chr19:43355048-43355947 | A549 | lung: | n/a | n/a |
7 | BATF | chr19:43442962-43443231 | GM12878 | blood: | n/a | n/a |
8 | BATF | chr19:43302238-43302533 | GM12878 | blood: | n/a | chr19:43302344-43302355 |
9 | BATF | chr19:43613006-43613315 | GM12878 | blood: | n/a | chr19:43613110-43613121 |
10 | BATF | chr19:43552186-43552537 | GM12878 | blood: | n/a | chr19:43552319-43552330 |
11 | BATF | chr19:43588401-43588710 | GM12878 | blood: | n/a | n/a |
12 | BATF | chr19:43271446-43271728 | GM12878 | blood: | n/a | n/a |
13 | BATF | chr19:43361555-43361754 | GM12878 | blood: | n/a | n/a |
14 | BATF | chr19:43552261-43552460 | GM12878 | blood: | n/a | chr19:43552319-43552330 |
15 | BATF | chr19:43591924-43592150 | GM12878 | blood: | n/a | n/a |
16 | BCL3 | chr19:43336292-43336877 | A549 | lung: | n/a | n/a |
17 | BCL3 | chr19:43335242-43336126 | A549 | lung: | n/a | chr19:43335602-43335611 chr19:43335603-43335612 |
18 | BCL3 | chr19:43297507-43298116 | A549 | lung: | n/a | n/a |
19 | BCL3 | chr19:43335292-43335990 | A549 | lung: | n/a | chr19:43335602-43335611 chr19:43335603-43335612 |
20 | BCL3 | chr19:43354910-43356058 | A549 | lung: | n/a | n/a |
21 | BCL3 | chr19:43354946-43356043 | A549 | lung: | n/a | n/a |
22 | BCL3 | chr19:43336972-43337663 | A549 | lung: | n/a | n/a |
23 | BCL3 | chr19:43336159-43337656 | A549 | lung: | n/a | chr19:43336227-43336234 |
24 | BCL3 | chr19:43323095-43323355 | GM12878 | blood: | n/a | n/a |
25 | BCL3 | chr19:43402518-43403428 | A549 | lung: | n/a | n/a |
26 | BHLHE40 | chr19:43582147-43582203 | K562 | blood: | n/a | n/a |
27 | BHLHE40 | chr19:43427453-43427512 | GM12878 | blood: | n/a | n/a |
28 | BHLHE40 | chr19:43385480-43385517 | K562 | blood: | n/a | n/a |
29 | BHLHE40 | chr19:43355572-43355890 | A549 | lung: | n/a | n/a |
30 | BRCA1 | chr19:43355288-43355847 | Hela-S3 | cervix: | n/a | n/a |
31 | BRCA1 | chr19:43624776-43624937 | Hela-S3 | cervix: | n/a | n/a |
32 | BRCA1 | chr19:43436723-43436914 | Hela-S3 | cervix: | n/a | n/a |
33 | BRCA1 | chr19:43297623-43297950 | Hela-S3 | cervix: | n/a | n/a |
34 | BRCA1 | chr19:43525934-43526309 | Hela-S3 | cervix: | n/a | n/a |
35 | CBX3 | chr19:43385505-43385738 | K562 | blood: | n/a | n/a |
36 | CBX3 | chr19:43385431-43385838 | K562 | blood: | n/a | n/a |
37 | CEBPB | chr19:43337225-43337426 | IMR90 | lung: | n/a | n/a |
38 | CEBPB | chr19:43510079-43510205 | HepG2 | liver: | n/a | chr19:43510191-43510202 |
39 | CEBPB | chr19:43496438-43496718 | IMR90 | lung: | n/a | n/a |
40 | CEBPB | chr19:43329190-43329511 | A549 | lung: | n/a | chr19:43329341-43329352 |
41 | CEBPB | chr19:43326599-43326799 | A549 | lung: | n/a | n/a |
42 | CEBPB | chr19:43525986-43526150 | A549 | lung: | n/a | n/a |
43 | CEBPB | chr19:43496454-43496723 | HepG2 | liver: | n/a | n/a |
44 | CEBPB | chr19:43355109-43355962 | IMR90 | lung: | n/a | n/a |
45 | CEBPB | chr19:43393825-43394224 | Hela-S3 | cervix: | n/a | n/a |
46 | CEBPB | chr19:43335434-43335820 | Hela-S3 | cervix: | n/a | n/a |
47 | CEBPB | chr19:43496486-43496642 | K562 | blood: | n/a | n/a |
48 | CEBPB | chr19:43496316-43496617 | A549 | lung: | n/a | n/a |
49 | CEBPB | chr19:43562984-43563042 | A549 | lung: | n/a | n/a |
50 | CEBPB | chr19:43634604-43634632 | HepG2 | liver: | n/a | chr19:43634618-43634629 chr19:43634616-43634629 chr19:43634616-43634629 chr19:43634616-43634627 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:43587500-43587550 | Jurkat | blood: | n/a |
2 | chr19:43587500-43587550 | Jurkat | blood: | n/a |
3 | chr19:43442809-43442859 | GM12892 | blood: | n/a |
4 | chr19:43530536-43530586 | SKMC | muscle: | n/a |
5 | chr19:43359870-43359920 | ECC-1 | luminal epithelium: | n/a |
6 | chr19:43383799-43383849 | SKMC | muscle: | n/a |
7 | chr19:43423176-43423226 | ECC-1 | luminal epithelium: | n/a |
8 | chr19:43360229-43360279 | SKMC | muscle: | n/a |
9 | chr19:43442804-43442854 | Jurkat | blood: | n/a |
10 | chr19:43442809-43442859 | HCT-116 | colon: | n/a |
11 | chr19:43355659-43355709 | SK-N-SH | brain: | n/a |
12 | chr19:43588055-43588105 | H1-hESC | embryonic stem cell: | embryo |
13 | chr19:43269877-43269927 | HCM | heart: | n/a |
14 | chr19:43530536-43530586 | HPAEpiC | pulmonary alveolar: | n/a |
15 | chr19:43385100-43385150 | HCPEpiC | choroid plexus: | n/a |
16 | chr19:43588069-43588119 | NH-A | brain: | n/a |
17 | chr19:43360229-43360279 | LNCaP | prostate: | n/a |
18 | chr19:43269832-43269882 | HIPEpiC | eye: | n/a |
19 | chr19:43384780-43384830 | MCF-7 | breast: | n/a |
20 | chr19:43587500-43587550 | HepG2 | liver: | n/a |
21 | chr19:43410455-43410505 | IMR90 | lung: | fetal |
22 | chr19:43588055-43588105 | AG04450 | lung: | fetal |
23 | chr19:43588025-43588075 | HRCEpiC | kidney: | n/a |
24 | chr19:43528994-43529044 | SK-N-SH_RA | brain: | n/a |
25 | chr19:43587500-43587550 | AG09309 | skin: | n/a |
26 | chr19:43271058-43271108 | LNCaP | prostate: | n/a |
27 | chr19:43359870-43359920 | PrEC | prostate: | n/a |
28 | chr19:43271004-43271054 | GM12892 | blood: | n/a |
29 | chr19:43359870-43359920 | HUVEC | blood vessel: | n/a |
30 | chr19:43271058-43271108 | U87 | brain: | n/a |
31 | chr19:43385047-43385097 | AG04450 | lung: | fetal |
32 | chr19:43269877-43269927 | HNPCEpiC | eye: | n/a |
33 | chr19:43442484-43442534 | GM12891 | blood: | n/a |
34 | chr19:43588069-43588119 | HRPEpiC | eye: | n/a |
35 | chr19:43359870-43359920 | HepG2 | liver: | n/a |
36 | chr19:43360755-43360805 | HPAEpiC | pulmonary alveolar: | n/a |
37 | chr19:43383799-43383849 | PFSK-1 | brain: | n/a |
38 | chr19:43442693-43442743 | PFSK-1 | brain: | n/a |
39 | chr19:43441294-43441344 | HepG2 | liver: | n/a |
40 | chr19:43441294-43441344 | AG10803 | skin: | n/a |
41 | chr19:43423115-43423165 | HRCEpiC | kidney: | n/a |
42 | chr19:43588069-43588119 | ProgFib | skin: | n/a |
43 | chr19:43269877-43269927 | HEEpiC | esophagus: | n/a |
44 | chr19:43383799-43383849 | GM12892 | blood: | n/a |
45 | chr19:43530536-43530586 | NHDF-neo | bronchial: | n/a |
46 | chr19:43360755-43360805 | HIPEpiC | eye: | n/a |
47 | chr19:43569592-43569642 | U87 | brain: | n/a |
48 | chr19:43587500-43587550 | MCF-7 | breast: | n/a |
49 | chr19:43588069-43588119 | T-47D | breast: | n/a |
50 | chr19:43423176-43423226 | GM12892 | blood: | n/a |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:43523469..43524084-chr19:43531918..43532440,2 | MCF-7 | breast: | |
2 | chr19:43523469..43524084-chr19:43531918..43532440,2 | MCF-7 | breast: | |
3 | chr19:43531581..43532101-chr2:1136088..1136613,2 | MCF-7 | breast: | |
4 | chr19:43608137..43608719-chr19:43820621..43821519,2 | MCF-7 | breast: | |
5 | chr19:43197633..43198568-chr19:43280847..43281639,2 | K562 | blood: | |
6 | chr19:43197647..43198196-chr19:43280850..43281744,2 | MCF-7 | breast: | |
7 | chr19:43297087..43297875-chr19:43423005..43423976,2 | MCF-7 | breast: |
(count:49 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PSG11-1 | chr19:43544526-43544780 | NONHSAT066579 |
2 | lnc-PSG6-1 | chr19:43440309-43440647 | NONHSAT066574 |
3 | lnc-PSG2-3 | chr19:43601248-43601512 | NONHSAT066582 |
4 | lnc-PSG1-1 | chr19:43343708-43343916 | NONHSAT146988 |
5 | lnc-PSG2-5 | chr19:43511982-43512194 | NONHSAT066576 |
6 | lnc-PSG1-1 | chr19:43343520-43343530 | NONHSAT146988 |
7 | lnc-PSG6-1 | chr19:43433594-43433872 | NR_073194 |
8 | lnc-PSG1-1 | chr19:43359708-43359870 | NONHSAT146988 |
9 | lnc-PSG6-1 | chr19:43429925-43430179 | NR_073194 |
10 | lnc-PSG1-1 | chr19:43570669-43570753 | NONHSAT066570 |
11 | lnc-PSG6-3 | chr19:43370618-43371302 | NONHSAT066572 |
12 | lnc-PSG1-1 | chr19:43359708-43359870 | NONHSAT066571 |
13 | lnc-PSG2-5 | chr19:43519268-43519426 | NONHSAT066577 |
14 | lnc-PSG1-1 | chr19:43341149-43341602 | NONHSAT066570 |
15 | lnc-PSG6-1 | chr19:43428284-43428976 | NR_073194 |
16 | lnc-PSG2-2 | chr19:43587104-43587197 | NONHSAT066580 |
17 | lnc-PSG6-1 | chr19:43441165-43441330 | NR_073194 |
18 | lnc-PSG2-1 | chr19:43586658-43586820 | NONHSAT066581 |
19 | lnc-PSG2-4 | chr19:43522922-43523199 | NONHSAT066578 |
20 | lnc-PSG6-2 | chr19:43453655-43453909 | NONHSAT066575 |
21 | lnc-PSG8-1 | chr19:43290505-43290747 | NONHSAT066567 |
22 | lnc-PSG1-1 | chr19:43358101-43358466 | NONHSAT146988 |
23 | lnc-PSG1-1 | chr19:43348511-43348765 | NONHSAT066571 |
24 | lnc-PSG2-2 | chr19:43576503-43576781 | NONHSAT066580 |
25 | lnc-PSG1-1 | chr19:43349168-43349446 | NONHSAT066571 |
26 | lnc-PSG1-1 | chr19:43343447-43343530 | NONHSAT066571 |
27 | lnc-PSG1-1 | chr19:43349168-43349446 | NONHSAT146988 |
28 | lnc-PSG8-1 | chr19:43289879-43290117 | NONHSAT066567 |
29 | lnc-PSG2-5 | chr19:43514422-43514579 | NONHSAT066577 |
30 | lnc-PSG8-1 | chr19:43285358-43285449 | NONHSAT066567 |
31 | lnc-PSG1-1 | chr19:43358101-43358466 | NONHSAT066571 |
32 | lnc-PSG1-1 | chr19:43341149-43341534 | NONHSAT066571 |
33 | lnc-PSG2-2 | chr19:43575923-43576106 | NONHSAT066580 |
34 | lnc-PSG6-1 | chr19:43441165-43441330 | NONHSAT066574 |
35 | lnc-PSG2-1 | chr19:43585939-43586423 | NONHSAT066581 |
36 | lnc-PSG6-3 | chr19:43372908-43374797 | NONHSAT066572 |
37 | lnc-PSG6-2 | chr19:43454299-43454539 | NONHSAT066575 |
38 | lnc-PSG2-4 | chr19:43521383-43521753 | NONHSAT066578 |
39 | lnc-PSG6-3 | chr19:43372253-43372507 | NONHSAT066572 |
40 | lnc-PSG2-5 | chr19:43514110-43514858 | NONHSAT066576 |
41 | lnc-PSG6-1 | chr19:43428286-43428976 | NONHSAT066573 |
42 | lnc-PSG11-1 | chr19:43540021-43540112 | NONHSAT066579 |
43 | lnc-PSG6-1 | chr19:43429925-43431729 | NONHSAT066573 |
44 | lnc-PSG1-1 | chr19:43348511-43348765 | NONHSAT146988 |
45 | lnc-PSG11-1 | chr19:43545168-43545400 | NONHSAT066579 |
46 | lnc-PSG6-1 | chr19:43430590-43430868 | NR_073194 |
47 | lnc-PSG1-1 | chr19:43343708-43343916 | NONHSAT066571 |
48 | lnc-PSG2-3 | chr19:43600608-43600855 | NONHSAT066582 |
49 | lnc-PSG6-1 | chr19:43439556-43439921 | NR_073194 |
No data |
No data |
Variant related genes | Relation type |
---|---|
CEACAMP7 | TF binding region |
CEACAMP9 | TF binding region |
PSG8 | TF binding region |
PSG11 | TF binding region |
ENSG00000225877 | TF binding region |
PSG6 | TF binding region |
CEACAMP6 | TF binding region |
CEACAMP8 | TF binding region |
PSG1 | TF binding region |
PSG2 | TF binding region |
PSG7 | TF binding region |
PSG10P | TF binding region |
CEACAMP7 | CpG island |
CEACAMP9 | CpG island |
PSG8 | CpG island |
PSG11 | CpG island |
ENSG00000225877 | CpG island |
PSG6 | CpG island |
CEACAMP6 | CpG island |
CEACAMP8 | CpG island |
PSG1 | CpG island |
PSG2 | CpG island |
PSG7 | CpG island |
PSG10P | CpG island |
ENSG00000170848 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146967288 | chr19:43268818-43268819 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs138006883 | chr19:43268850-43268851 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs181983943 | chr19:43268851-43268852 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546538023 | chr19:43268857-43268858 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs367699171 | chr19:43268862-43268863 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs546468399 | chr19:43268903-43268904 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs559986812 | chr19:43268907-43268908 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs573418496 | chr19:43268909-43268910 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs570120186 | chr19:43268914-43268915 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs542515074 | chr19:43268916-43268917 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs560062337 | chr19:43268918-43268919 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529658976 | chr19:43268927-43268928 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs184771045 | chr19:43268934-43268935 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs149034646 | chr19:43268940-43268941 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs189206090 | chr19:43268958-43268959 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181623078 | chr19:43268971-43268972 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs539972051 | chr19:43268975-43268976 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs143007584 | chr19:43269003-43269004 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs528327915 | chr19:43269014-43269015 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs576475291 | chr19:43269020-43269021 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs148171623 | chr19:43269021-43269022 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs371845563 | chr19:43269022-43269023 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs200981263 | chr19:43269031-43269032 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs76435895 | chr19:43269038-43269039 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs557489534 | chr19:43269039-43269040 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs570998102 | chr19:43269083-43269084 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs539949239 | chr19:43269087-43269088 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs76688983 | chr19:43269105-43269106 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs369089716 | chr19:43269107-43269108 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs186740033 | chr19:43269116-43269117 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs191134744 | chr19:43269119-43269120 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs181115583 | chr19:43269135-43269136 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs574071448 | chr19:43269167-43269168 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs186048311 | chr19:43269202-43269203 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs530290104 | chr19:43269208-43269209 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs534073266 | chr19:43269209-43269210 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs113131452 | chr19:43269214-43269215 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs371886244 | chr19:43269215-43269216 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs375483870 | chr19:43269220-43269221 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs545885869 | chr19:43269221-43269222 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs559252882 | chr19:43269259-43269260 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs372970245 | chr19:43269260-43269261 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs553763507 | chr19:43269309-43269310 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542075541 | chr19:43269311-43269312 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs548172451 | chr19:43269318-43269319 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs568411427 | chr19:43269320-43269321 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs530919544 | chr19:43269325-43269326 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs189589309 | chr19:43269348-43269349 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs570863026 | chr19:43269356-43269357 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs539915308 | chr19:43269361-43269362 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 22495311 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21364760 | CNVD |
Invasive pancreatic ductal carcinoma | 18765526 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Breast cancer | 20409316 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Astrocytoma | 22246337 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21509527 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Ependymoma | 20639864 | CNVD |
Autism | 19492091 | CNVD |
Ovarian cancer | 20800559 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Spondylocostal dysostosis | 21085971 | CNVD |
Nicotine metabolism | 21956041 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Melanoma | 20877625 | CNVD |
Ovarian cancer | 21240255 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Primary Severe Spermatogenic Failure | 20378930 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:43266600-43269800 | Active TSS | Placenta | Placenta |
2 | chr19:43267200-43269600 | Weak transcription | Esophagus | oesophagus |
3 | chr19:43267200-43271000 | Weak transcription | Pancreas | Pancrea |
4 | chr19:43267800-43269000 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
5 | chr19:43268400-43269800 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
6 | chr19:43268400-43269800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
7 | chr19:43268600-43269200 | Enhancers | NHDF-Ad | bronchial |
8 | chr19:43268800-43269000 | Enhancers | Hela-S3 | cervix |
9 | chr19:43268800-43269000 | Enhancers | HSMM | muscle |
10 | chr19:43268800-43269000 | Enhancers | NHLF | lung |
11 | chr19:43268800-43269400 | Enhancers | Muscle Satellite Cultured Cells | -- |
12 | chr19:43269000-43269400 | Weak transcription | Hela-S3 | cervix |
13 | chr19:43269000-43269800 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
14 | chr19:43269200-43269400 | Enhancers | Osteobl | bone |
15 | chr19:43269400-43269800 | Enhancers | Hela-S3 | cervix |
16 | chr19:43269600-43269800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr19:43269600-43269800 | Enhancers | Esophagus | oesophagus |
18 | chr19:43269800-43270800 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
19 | chr19:43269800-43271000 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
20 | chr19:43269800-43278800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
21 | chr19:43270800-43271200 | ZNF genes & repeats | Foreskin Fibroblast Primary Cells skin02 | Skin |
22 | chr19:43271000-43271400 | ZNF genes & repeats | Foreskin Fibroblast Primary Cells skin01 | Skin |
23 | chr19:43271000-43271400 | Enhancers | Placenta | Placenta |
24 | chr19:43271000-43271400 | ZNF genes & repeats | Pancreas | Pancrea |
25 | chr19:43271000-43271400 | Active TSS | Spleen | Spleen |
26 | chr19:43271400-43278800 | Weak transcription | Pancreas | Pancrea |
27 | chr19:43278400-43279200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
28 | chr19:43278600-43278800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
29 | chr19:43278800-43279000 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
30 | chr19:43278800-43279000 | Active TSS | iPS-18 Cell Line | embryonic stem cell |
31 | chr19:43278800-43279000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
32 | chr19:43278800-43279000 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
33 | chr19:43278800-43279200 | ZNF genes & repeats | H9 Cell Line | embryonic stem cell |
34 | chr19:43278800-43279200 | ZNF genes & repeats | HUES6 Cell Line | embryonic stem cell |
35 | chr19:43278800-43279200 | ZNF genes & repeats | HUES64 Cell Line | embryonic stem cell |
36 | chr19:43278800-43279200 | ZNF genes & repeats | iPS DF 6.9 Cell Line | embryonic stem cell |
37 | chr19:43278800-43279200 | Enhancers | Pancreas | Pancrea |
38 | chr19:43278800-43279400 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
39 | chr19:43278800-43279400 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
40 | chr19:43279000-43279200 | Flanking Active TSS | ES-WA7 Cell Line | embryonic stem cell |
41 | chr19:43279000-43279200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
42 | chr19:43279000-43279200 | Flanking Active TSS | iPS-18 Cell Line | embryonic stem cell |
43 | chr19:43279000-43279200 | ZNF genes & repeats | iPS-20b Cell Line | embryonic stem cell |
44 | chr19:43279000-43279200 | Flanking Bivalent TSS/Enh | iPS DF 19.11 Cell Line | embryonic stem cell |
45 | chr19:43279000-43279200 | ZNF genes & repeats | Duodenum Smooth Muscle | Duodenum |
46 | chr19:43279000-43279200 | Bivalent Enhancer | Left Ventricle | heart |
47 | chr19:43279000-43281000 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
48 | chr19:43279200-43281000 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
49 | chr19:43279200-43281800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
50 | chr19:43281000-43281200 | Enhancers | Brain Substantia Nigra | brain |